SAS' Jennifer Hargrove introduces the SAS Medication Adherence Risk model, a way to identify patients at high risk of being non-adherent to their medication therapy so that interventions can be provided to help patients remain adherent.
SAS' Jennifer Hargrove introduces the SAS Medication Adherence Risk model, a way to identify patients at high risk of being non-adherent to their medication therapy so that interventions can be provided to help patients remain adherent.
When the SAS Global Forum 2020 conference was cancelled by the global COVID-19 pandemic, I felt sorry for the customers and colleagues who had spent months preparing their presentations. One presentation I especially wanted to attend was by Bucky Ransdell and Randy Tobias: "Introducing PROC SIMSYSTEM for Systematic Nonnormal Simulation".
En la era de la transformación digital, la velocidad, la escalabilidad y la rentabilidad no son solo indicadores de desempeño; son factores decisivos que permiten a las empresas mantenerse competitivas. Hoy, en SAS, nos enorgullecemos de ver cómo nuestra plataforma de IA y analítica, SAS Viya, no solo cumple con